Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

US Patent 11629349 · Granted Apr 18, 2023

Estimated economic value: $44,599,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
Compositions and methods comprising histidyl-tRNA synthetase splice variants hav2025
RNAi agents for inhibiting expression of receptor for advanced glycation end-pro2025
5′-cyclo-phosphonate modified nucleotides2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), 2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025
Alpha-v beta-6 integrin ligands and uses thereof2024